{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:50:31Z","timestamp":1790319031066,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0901504"],"award-info":[{"award-number":["2016YFC0901504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2017YFC0909101"],"award-info":[{"award-number":["2017YFC0909101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.parkreldis.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T21:03:02Z","timestamp":1524430982000},"page":"68-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Survival analysis and prognostic nomogram model for multiple system atrophy"],"prefix":"10.1016","volume":"54","author":[{"given":"Bei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Hui-Fang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.04.016_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","article-title":"Survival of patients with pathologically proven multiple system atrophy: a meta-analysis","volume":"48","author":"Ben-Shlomo","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mds.23580","article-title":"Survival of Korean patients with multiple system atrophy","volume":"26","author":"Kim","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: a prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O'Sullivan","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12311-015-0668-6","article-title":"Epidemiology of multiple system atrophy in Hokkaido, the Northernmost Island of Japan","volume":"14","author":"Sakushima","year":"2015","journal-title":"Cerebellum"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib9","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/brain\/awv274","article-title":"Clinical features and autonomic testing predict survival in multiple system atrophy","volume":"138","author":"Coon","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.25927","article-title":"Multiple system atrophy: prognostic indicators of survival","volume":"29","author":"Figueroa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2169\/internalmedicine.33.321","article-title":"Survival of patients with multiple system atrophy","volume":"33","author":"Saito","year":"1994","journal-title":"Intern. Med."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.598","article-title":"Serum uric acid levels in Parkinson's disease and related disorders","volume":"7","author":"Sakuta","year":"2017","journal-title":"Brain Behav"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1179\/1743132813Y.0000000277","article-title":"Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population","volume":"36","author":"Cao","year":"2014","journal-title":"Neurol. Res."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1179\/1743132815Y.0000000095","article-title":"Serum creatinine is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population","volume":"38","author":"Cao","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib17","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1182\/blood-2005-12-051458","article-title":"Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia","volume":"109","author":"Wierda","year":"2007","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.parkreldis.2018.04.016_bib18","doi-asserted-by":"crossref","first-page":"31775","DOI":"10.18632\/oncotarget.15990","article-title":"AHNAK2 is a potential prognostic biomarker in patients with PDAC","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mds.26220","article-title":"Minimal change multiple system atrophy: an aggressive variant?","volume":"30","author":"Ling","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archneur.64.2.256","article-title":"Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy","volume":"64","author":"Tada","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.410430205","article-title":"Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure","volume":"43","author":"Benarroch","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.20021","article-title":"Involvement of medullary serotonergic groups in multiple system atrophy","volume":"55","author":"Benarroch","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib24","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awp110","article-title":"Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death","volume":"132","author":"Tada","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/jnnp-2014-309999","article-title":"New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study","volume":"87","author":"Pavy-Le Traon","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib26","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","article-title":"The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial","volume":"53","author":"Freeman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.04.016_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000069077","article-title":"Laryngeal stridor in multiple system atrophy","volume":"49","author":"Yamaguchi","year":"2003","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.parkreldis.2018.04.016_bib29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.0000000000003156","article-title":"Early stridor onset and stridor treatment predict survival in 136 patients with MSA","volume":"87","author":"Giannini","year":"2016","journal-title":"Neurology"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:39:05Z","timestamp":1589881145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018302049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"alternative-id":["S1353802018302049"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.016","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival analysis and prognostic nomogram model for multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}